Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v6-FR
Language French French
Date Updated 2020-04-01 2020-01-22
Drug Identification Number 00441643 00441643
Brand name APO-IBUPROFEN TAB 200MG APO-IBUPROFEN TAB 200MG
Common or Proper name IBUPROFEN TAB IBUPROFEN TAB
Company Name APOTEX INC APOTEX INC
Ingredients IBUPROFEN IBUPROFEN
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1000 BTL 1000 BTL
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2019-02-20 2019-02-20
Estimated end date 2020-04-03 2020-03-13
Actual end date 2020-03-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments